Black patients with kidney cancer have poorer survival than whites

Among patients with the most common form of kidney cancer, whites consistently have a survival advantage over blacks, regardless of patient and tumor characteristics or surgical treatment. That is the conclusion of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study's results suggest that additional efforts are needed to prolong the survival of all patients with kidney cancer.

Since the mid-1990s, black Americans have had a higher incidence of renal cell carcinoma, the most common form of , than white Americans. Research also suggests that there are in the survival of patients with renal cell carcinoma, with black patients dying earlier than whites.

When Wong-Ho Chow, PhD, currently of The University of Texas MD Anderson Cancer Center in Houston, and her colleagues at the analyzed national data of nearly 40,000 patients, they confirmed the poorer survival rates for black patients compared with whites. Specifically, 72.6 percent of white patients survived for at least five years, compared with 68.0 percent of black patients. The survival advantage of white patients over black patients was consistently seen in all subgroups of patients, regardless of gender, age, tumor stage or size, tumor subtype, or type of surgical treatment.

Surprisingly, a higher percentage of black patients than white patients were diagnosed at the localized stage, with smaller tumors, or with a less aggressive subtype of cancer. These factors should indicate a better prognosis. Also, compared with white patients, a slightly higher percentage of black patients received no surgical treatment, which is associated with a substantially poorer prognosis.

Additional studies are needed to determine why these disparities exist. "We cannot rule out the possibility that other factors not measured in our study—such as obesity, high blood pressure, access to care, and genetic susceptibility—may be contributing to the persistent disparities," said Dr. Chow.

More information: "Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics." Wong-Ho Chow, Brian Shuch, W. Marston Linehan, Susan S. Devesa. CANCER; Published Online: November 12, 2012 DOI: 10.1002/cncr.27690

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.